Related Experiment Video
Updated: Jul 14, 2026

An In Vitro Approach to Study Mitochondrial Dysfunction: A Cybrid Model
Published on: March 9, 2022
Vagus nerve stimulation in children with mitochondrial electron transport chain deficiencies
Todd M Arthur1, Russell P Saneto, Marcio Sotero de Menezes
1Division of Pediatric Neurology, Children's Hospital and Regional Medical Center/University of Washington, B-5552, 4800 Sand Point Way NE, Seattle, WA 98105, USA.
Insights
Vagus nerve stimulation (VNS) showed limited effectiveness in reducing seizure frequency in five young children with intractable epilepsy and mitochondrial disease. This epilepsy treatment may not be suitable for myoclonic seizures in electron transport chain disorders.
Area of Science:
- Pediatric Neurology
- Mitochondrial Diseases
- Epilepsy Treatment
Background:
- Intractable seizures in children often require advanced treatment options.
- Mitochondrial diseases, particularly electron transport chain deficiencies, can cause severe neurological symptoms like epilepsy.
- Vagus nerve stimulation (VNS) is an established therapy for refractory epilepsy.
Purpose of the Study:
- To evaluate the efficacy of vagus nerve stimulation (VNS) in pediatric patients under 12 years old with intractable seizures and mitochondrial disease.
- To analyze seizure frequency reduction and other clinical outcomes following VNS implantation in this specific patient cohort.
Main Methods:
- Retrospective investigation of outcome data from five children diagnosed with mitochondrial disease and intractable seizures.
- Data collection included seizure types/frequency, EEG, neuroimaging, and medication history before and after VNS implantation.
Main Results:
- None of the five pediatric patients experienced a significant reduction in seizure frequency with VNS.
- Four children presented with predominantly myoclonic seizures; one had focal seizures with secondary generalization and myoclonic seizures.
Conclusions:
- Vagus nerve stimulation (VNS) appears to be ineffective for controlling myoclonic seizures in children with electron transport chain disorders.
- Further research is needed to explore alternative or adjunctive therapies for epilepsy in pediatric mitochondrial diseases.
Abstract:
We retrospectively investigated outcome data for vagus nerve stimulation (VNS) in children less than 12 years of age with intractable seizures and mitochondrial disease. Five children with a mitochondrial disease, due to electron transport chain deficiency, were studied. Information was collected from clinic visits prior to, and subsequent to, VNS implantation. Data were collected by type and frequency of seizures, encephalogram and neuroimaging findings, and medication history. Four of the children had predominantly myoclonic seizures, while the other child had focal seizures with secondary generalization and myoclonic seizures. All five children did not have significant reduction in seizure frequency with VNS. VNS may not be an effective method to control myoclonic seizures in children with electron transport chain disorders.
Related Concept Videos
Motor Unit Stimulation
The latent period of contraction marks the onset of excitation-contraction coupling, when the action potential propagates across the sarcolemma, preparing the muscle fibers for contraction. As the fibers enter the contraction phase, the...
Animal Mitochondrial Genetics
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...

